Click for best price
Human Genetically Engineered Vaccine Market Size, Share 2024
The global Human Genetically Engineered Vaccine market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Genetic Recombinant Vaccine Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Human Genetically Engineered Vaccine include Pfizer, Merck, GSK, Beijing Wantai Biological Pharmacy Enterprise CO.,LTD., Walvax Biotechnology Co., Ltd., Bharat Biotech, Chengdu Kanghua Biological Products Co., Ltd., South China Vaccine Corporation Limited and Beijing Health Guard Biotechnology Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Human Genetically Engineered Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Genetically Engineered Vaccine. This report contains market size and forecasts of Human Genetically Engineered Vaccine in global, including the following market information:
Global Human Genetically Engineered Vaccine Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Human Genetically Engineered Vaccine Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Human Genetically Engineered Vaccine companies in 2023 (%)
We surveyed the Human Genetically Engineered Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Genetically Engineered Vaccine Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Human Genetically Engineered Vaccine Market Segment Percentages, by Type, 2023 (%)
Genetic Recombinant Vaccine
Recombinant Subunit Vaccines
Genetic Vaccine
Global Human Genetically Engineered Vaccine Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Human Genetically Engineered Vaccine Market Segment Percentages, by Application, 2023 (%)
Hepatitis E
Human Papillomavirus (HPV)
Rotavirus
Others
Global Human Genetically Engineered Vaccine Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Human Genetically Engineered Vaccine Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Genetically Engineered Vaccine revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Human Genetically Engineered Vaccine revenues share in global market, 2023 (%)
Key companies Human Genetically Engineered Vaccine sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Human Genetically Engineered Vaccine sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Merck
GSK
Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
Walvax Biotechnology Co., Ltd.
Bharat Biotech
Chengdu Kanghua Biological Products Co., Ltd.
South China Vaccine Corporation Limited
Beijing Health Guard Biotechnology Inc.
CSL Limited
Emergent BioSolutions
Sanofi Pasteur
Serum Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Genetically Engineered Vaccine, market overview.
Chapter 2: Global Human Genetically Engineered Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Human Genetically Engineered Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Genetically Engineered Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Genetically Engineered Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Human Genetically Engineered Vaccine Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Human Genetically Engineered Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Genetically Engineered Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Genetically Engineered Vaccine Overall Market Size
2.1 Global Human Genetically Engineered Vaccine Market Size: 2023 VS 2030
2.2 Global Human Genetically Engineered Vaccine Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Human Genetically Engineered Vaccine Sales: 2019-2030
3 Company Landscape
3.1 Top Human Genetically Engineered Vaccine Players in Global Market
3.2 Top Global Human Genetically Engineered Vaccine Companies Ranked by Revenue
3.3 Global Human Genetically Engineered Vaccine Revenue by Companies
3.4 Global Human Genetically Engineered Vaccine Sales by Companies
3.5 Global Human Genetically Engineered Vaccine Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Human Genetically Engineered Vaccine Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Human Genetically Engineered Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Genetically Engineered Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Human Genetically Engineered Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Genetically Engineered Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Genetically Engineered Vaccine Market Size Markets, 2023 & 2030
4.1.2 Genetic Recombinant Vaccine
4.1.3 Recombinant Subunit Vaccines
4.1.4 Genetic Vaccine
4.2 By Type - Global Human Genetically Engineered Vaccine Revenue & Forecasts
4.2.1 By Type - Global Human Genetically Engineered Vaccine Revenue, 2019-2024
4.2.2 By Type - Global Human Genetically Engineered Vaccine Revenue, 2025-2030
4.2.3 By Type - Global Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
4.3 By Type - Global Human Genetically Engineered Vaccine Sales & Forecasts
4.3.1 By Type - Global Human Genetically Engineered Vaccine Sales, 2019-2024
4.3.2 By Type - Global Human Genetically Engineered Vaccine Sales, 2025-2030
4.3.3 By Type - Global Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
4.4 By Type - Global Human Genetically Engineered Vaccine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Genetically Engineered Vaccine Market Size, 2023 & 2030
5.1.2 Hepatitis E
5.1.3 Human Papillomavirus (HPV)
5.1.4 Rotavirus
5.1.5 Others
5.2 By Application - Global Human Genetically Engineered Vaccine Revenue & Forecasts
5.2.1 By Application - Global Human Genetically Engineered Vaccine Revenue, 2019-2024
5.2.2 By Application - Global Human Genetically Engineered Vaccine Revenue, 2025-2030
5.2.3 By Application - Global Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
5.3 By Application - Global Human Genetically Engineered Vaccine Sales & Forecasts
5.3.1 By Application - Global Human Genetically Engineered Vaccine Sales, 2019-2024
5.3.2 By Application - Global Human Genetically Engineered Vaccine Sales, 2025-2030
5.3.3 By Application - Global Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
5.4 By Application - Global Human Genetically Engineered Vaccine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Human Genetically Engineered Vaccine Market Size, 2023 & 2030
6.2 By Region - Global Human Genetically Engineered Vaccine Revenue & Forecasts
6.2.1 By Region - Global Human Genetically Engineered Vaccine Revenue, 2019-2024
6.2.2 By Region - Global Human Genetically Engineered Vaccine Revenue, 2025-2030
6.2.3 By Region - Global Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
6.3 By Region - Global Human Genetically Engineered Vaccine Sales & Forecasts
6.3.1 By Region - Global Human Genetically Engineered Vaccine Sales, 2019-2024
6.3.2 By Region - Global Human Genetically Engineered Vaccine Sales, 2025-2030
6.3.3 By Region - Global Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Human Genetically Engineered Vaccine Revenue, 2019-2030
6.4.2 By Country - North America Human Genetically Engineered Vaccine Sales, 2019-2030
6.4.3 US Human Genetically Engineered Vaccine Market Size, 2019-2030
6.4.4 Canada Human Genetically Engineered Vaccine Market Size, 2019-2030
6.4.5 Mexico Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Human Genetically Engineered Vaccine Revenue, 2019-2030
6.5.2 By Country - Europe Human Genetically Engineered Vaccine Sales, 2019-2030
6.5.3 Germany Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5.4 France Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5.5 U.K. Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5.6 Italy Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5.7 Russia Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5.8 Nordic Countries Human Genetically Engineered Vaccine Market Size, 2019-2030
6.5.9 Benelux Human Genetically Engineered Vaccine Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Human Genetically Engineered Vaccine Revenue, 2019-2030
6.6.2 By Region - Asia Human Genetically Engineered Vaccine Sales, 2019-2030
6.6.3 China Human Genetically Engineered Vaccine Market Size, 2019-2030
6.6.4 Japan Human Genetically Engineered Vaccine Market Size, 2019-2030
6.6.5 South Korea Human Genetically Engineered Vaccine Market Size, 2019-2030
6.6.6 Southeast Asia Human Genetically Engineered Vaccine Market Size, 2019-2030
6.6.7 India Human Genetically Engineered Vaccine Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Human Genetically Engineered Vaccine Revenue, 2019-2030
6.7.2 By Country - South America Human Genetically Engineered Vaccine Sales, 2019-2030
6.7.3 Brazil Human Genetically Engineered Vaccine Market Size, 2019-2030
6.7.4 Argentina Human Genetically Engineered Vaccine Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Genetically Engineered Vaccine Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Human Genetically Engineered Vaccine Sales, 2019-2030
6.8.3 Turkey Human Genetically Engineered Vaccine Market Size, 2019-2030
6.8.4 Israel Human Genetically Engineered Vaccine Market Size, 2019-2030
6.8.5 Saudi Arabia Human Genetically Engineered Vaccine Market Size, 2019-2030
6.8.6 UAE Human Genetically Engineered Vaccine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Human Genetically Engineered Vaccine Major Product Offerings
7.1.4 Pfizer Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.1.5 Pfizer Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Human Genetically Engineered Vaccine Major Product Offerings
7.2.4 Merck Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.2.5 Merck Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Human Genetically Engineered Vaccine Major Product Offerings
7.3.4 GSK Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.3.5 GSK Key News & Latest Developments
7.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
7.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Summary
7.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Business Overview
7.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Major Product Offerings
7.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Key News & Latest Developments
7.5 Walvax Biotechnology Co., Ltd.
7.5.1 Walvax Biotechnology Co., Ltd. Company Summary
7.5.2 Walvax Biotechnology Co., Ltd. Business Overview
7.5.3 Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Major Product Offerings
7.5.4 Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.5.5 Walvax Biotechnology Co., Ltd. Key News & Latest Developments
7.6 Bharat Biotech
7.6.1 Bharat Biotech Company Summary
7.6.2 Bharat Biotech Business Overview
7.6.3 Bharat Biotech Human Genetically Engineered Vaccine Major Product Offerings
7.6.4 Bharat Biotech Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.6.5 Bharat Biotech Key News & Latest Developments
7.7 Chengdu Kanghua Biological Products Co., Ltd.
7.7.1 Chengdu Kanghua Biological Products Co., Ltd. Company Summary
7.7.2 Chengdu Kanghua Biological Products Co., Ltd. Business Overview
7.7.3 Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Major Product Offerings
7.7.4 Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.7.5 Chengdu Kanghua Biological Products Co., Ltd. Key News & Latest Developments
7.8 South China Vaccine Corporation Limited
7.8.1 South China Vaccine Corporation Limited Company Summary
7.8.2 South China Vaccine Corporation Limited Business Overview
7.8.3 South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Major Product Offerings
7.8.4 South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.8.5 South China Vaccine Corporation Limited Key News & Latest Developments
7.9 Beijing Health Guard Biotechnology Inc.
7.9.1 Beijing Health Guard Biotechnology Inc. Company Summary
7.9.2 Beijing Health Guard Biotechnology Inc. Business Overview
7.9.3 Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Major Product Offerings
7.9.4 Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.9.5 Beijing Health Guard Biotechnology Inc. Key News & Latest Developments
7.10 CSL Limited
7.10.1 CSL Limited Company Summary
7.10.2 CSL Limited Business Overview
7.10.3 CSL Limited Human Genetically Engineered Vaccine Major Product Offerings
7.10.4 CSL Limited Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.10.5 CSL Limited Key News & Latest Developments
7.11 Emergent BioSolutions
7.11.1 Emergent BioSolutions Company Summary
7.11.2 Emergent BioSolutions Human Genetically Engineered Vaccine Business Overview
7.11.3 Emergent BioSolutions Human Genetically Engineered Vaccine Major Product Offerings
7.11.4 Emergent BioSolutions Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.11.5 Emergent BioSolutions Key News & Latest Developments
7.12 Sanofi Pasteur
7.12.1 Sanofi Pasteur Company Summary
7.12.2 Sanofi Pasteur Human Genetically Engineered Vaccine Business Overview
7.12.3 Sanofi Pasteur Human Genetically Engineered Vaccine Major Product Offerings
7.12.4 Sanofi Pasteur Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.12.5 Sanofi Pasteur Key News & Latest Developments
7.13 Serum Institute
7.13.1 Serum Institute Company Summary
7.13.2 Serum Institute Human Genetically Engineered Vaccine Business Overview
7.13.3 Serum Institute Human Genetically Engineered Vaccine Major Product Offerings
7.13.4 Serum Institute Human Genetically Engineered Vaccine Sales and Revenue in Global (2019-2024)
7.13.5 Serum Institute Key News & Latest Developments
8 Global Human Genetically Engineered Vaccine Production Capacity, Analysis
8.1 Global Human Genetically Engineered Vaccine Production Capacity, 2019-2030
8.2 Human Genetically Engineered Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Genetically Engineered Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Genetically Engineered Vaccine Supply Chain Analysis
10.1 Human Genetically Engineered Vaccine Industry Value Chain
10.2 Human Genetically Engineered Vaccine Upstream Market
10.3 Human Genetically Engineered Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Genetically Engineered Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Human Genetically Engineered Vaccine in Global Market
Table 2. Top Human Genetically Engineered Vaccine Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Human Genetically Engineered Vaccine Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Human Genetically Engineered Vaccine Revenue Share by Companies, 2019-2024
Table 5. Global Human Genetically Engineered Vaccine Sales by Companies, (K Units), 2019-2024
Table 6. Global Human Genetically Engineered Vaccine Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Human Genetically Engineered Vaccine Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Human Genetically Engineered Vaccine Product Type
Table 9. List of Global Tier 1 Human Genetically Engineered Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Genetically Engineered Vaccine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Human Genetically Engineered Vaccine Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Human Genetically Engineered Vaccine Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Human Genetically Engineered Vaccine Sales (K Units), 2019-2024
Table 15. By Type - Global Human Genetically Engineered Vaccine Sales (K Units), 2025-2030
Table 16. By Application ? Global Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Human Genetically Engineered Vaccine Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Human Genetically Engineered Vaccine Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Human Genetically Engineered Vaccine Sales (K Units), 2019-2024
Table 20. By Application - Global Human Genetically Engineered Vaccine Sales (K Units), 2025-2030
Table 21. By Region ? Global Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Human Genetically Engineered Vaccine Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Human Genetically Engineered Vaccine Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Human Genetically Engineered Vaccine Sales (K Units), 2019-2024
Table 25. By Region - Global Human Genetically Engineered Vaccine Sales (K Units), 2025-2030
Table 26. By Country - North America Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Human Genetically Engineered Vaccine Sales, (K Units), 2019-2024
Table 29. By Country - North America Human Genetically Engineered Vaccine Sales, (K Units), 2025-2030
Table 30. By Country - Europe Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Human Genetically Engineered Vaccine Sales, (K Units), 2019-2024
Table 33. By Country - Europe Human Genetically Engineered Vaccine Sales, (K Units), 2025-2030
Table 34. By Region - Asia Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Human Genetically Engineered Vaccine Sales, (K Units), 2019-2024
Table 37. By Region - Asia Human Genetically Engineered Vaccine Sales, (K Units), 2025-2030
Table 38. By Country - South America Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Human Genetically Engineered Vaccine Sales, (K Units), 2019-2024
Table 41. By Country - South America Human Genetically Engineered Vaccine Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Human Genetically Engineered Vaccine Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Human Genetically Engineered Vaccine Sales, (K Units), 2025-2030
Table 46. Pfizer Company Summary
Table 47. Pfizer Human Genetically Engineered Vaccine Product Offerings
Table 48. Pfizer Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Pfizer Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Human Genetically Engineered Vaccine Product Offerings
Table 52. Merck Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Merck Key News & Latest Developments
Table 54. GSK Company Summary
Table 55. GSK Human Genetically Engineered Vaccine Product Offerings
Table 56. GSK Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. GSK Key News & Latest Developments
Table 58. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Company Summary
Table 59. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Product Offerings
Table 60. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Key News & Latest Developments
Table 62. Walvax Biotechnology Co., Ltd. Company Summary
Table 63. Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Product Offerings
Table 64. Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Walvax Biotechnology Co., Ltd. Key News & Latest Developments
Table 66. Bharat Biotech Company Summary
Table 67. Bharat Biotech Human Genetically Engineered Vaccine Product Offerings
Table 68. Bharat Biotech Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Bharat Biotech Key News & Latest Developments
Table 70. Chengdu Kanghua Biological Products Co., Ltd. Company Summary
Table 71. Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Product Offerings
Table 72. Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Chengdu Kanghua Biological Products Co., Ltd. Key News & Latest Developments
Table 74. South China Vaccine Corporation Limited Company Summary
Table 75. South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Product Offerings
Table 76. South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. South China Vaccine Corporation Limited Key News & Latest Developments
Table 78. Beijing Health Guard Biotechnology Inc. Company Summary
Table 79. Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Product Offerings
Table 80. Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Beijing Health Guard Biotechnology Inc. Key News & Latest Developments
Table 82. CSL Limited Company Summary
Table 83. CSL Limited Human Genetically Engineered Vaccine Product Offerings
Table 84. CSL Limited Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. CSL Limited Key News & Latest Developments
Table 86. Emergent BioSolutions Company Summary
Table 87. Emergent BioSolutions Human Genetically Engineered Vaccine Product Offerings
Table 88. Emergent BioSolutions Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Emergent BioSolutions Key News & Latest Developments
Table 90. Sanofi Pasteur Company Summary
Table 91. Sanofi Pasteur Human Genetically Engineered Vaccine Product Offerings
Table 92. Sanofi Pasteur Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Sanofi Pasteur Key News & Latest Developments
Table 94. Serum Institute Company Summary
Table 95. Serum Institute Human Genetically Engineered Vaccine Product Offerings
Table 96. Serum Institute Human Genetically Engineered Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Serum Institute Key News & Latest Developments
Table 98. Human Genetically Engineered Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 99. Global Human Genetically Engineered Vaccine Capacity Market Share of Key Manufacturers, 2021-2024
Table 100. Global Human Genetically Engineered Vaccine Production by Region, 2019-2024 (K Units)
Table 101. Global Human Genetically Engineered Vaccine Production by Region, 2025-2030 (K Units)
Table 102. Human Genetically Engineered Vaccine Market Opportunities & Trends in Global Market
Table 103. Human Genetically Engineered Vaccine Market Drivers in Global Market
Table 104. Human Genetically Engineered Vaccine Market Restraints in Global Market
Table 105. Human Genetically Engineered Vaccine Raw Materials
Table 106. Human Genetically Engineered Vaccine Raw Materials Suppliers in Global Market
Table 107. Typical Human Genetically Engineered Vaccine Downstream
Table 108. Human Genetically Engineered Vaccine Downstream Clients in Global Market
Table 109. Human Genetically Engineered Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Genetically Engineered Vaccine Segment by Type in 2023
Figure 2. Human Genetically Engineered Vaccine Segment by Application in 2023
Figure 3. Global Human Genetically Engineered Vaccine Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Human Genetically Engineered Vaccine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Human Genetically Engineered Vaccine Revenue, 2019-2030 (US$, Mn)
Figure 7. Human Genetically Engineered Vaccine Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Genetically Engineered Vaccine Revenue in 2023
Figure 9. By Type - Global Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 11. By Type - Global Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 12. By Type - Global Human Genetically Engineered Vaccine Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 15. By Application - Global Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 16. By Application - Global Human Genetically Engineered Vaccine Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Human Genetically Engineered Vaccine Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 20. By Region - Global Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 21. By Country - North America Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 22. By Country - North America Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 23. US Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 28. Germany Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 29. France Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 37. China Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 41. India Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 43. By Country - South America Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 44. Brazil Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Human Genetically Engineered Vaccine Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Human Genetically Engineered Vaccine Sales Market Share, 2019-2030
Figure 48. Turkey Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Human Genetically Engineered Vaccine Revenue, (US$, Mn), 2019-2030
Figure 52. Global Human Genetically Engineered Vaccine Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Human Genetically Engineered Vaccine by Region, 2023 VS 2030
Figure 54. Human Genetically Engineered Vaccine Industry Value Chain
Figure 55. Marketing Channels
